Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
$254.07M
Ms. Jennifer L. Good
23.00
New Haven, CT
May 07, 2019
-9.21
$-0.38
2.92
21.06
0.00%
-4.66
1.34
0.00
19.99
-27.05%
-26.38%
Similar stocks (17)
Cullinan Oncology, Inc.
CGEM
ORIC Pharmaceuticals, Inc.
ORIC
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Rezolute, Inc.
RZLT
Prelude Therapeutics Incorporated
PRLD
Coherus BioSciences, Inc.
CHRS
Seer, Inc.
SEER
BioAtla, Inc.
BCAB
Spero Therapeutics, Inc.
SPRO
Anebulo Pharmaceuticals, Inc.
ANEB
Protara Therapeutics, Inc.
TARA
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
Bolt Biotherapeutics, Inc.
BOLT
Lyra Therapeutics, Inc.
LYRA
TRACON Pharmaceuticals, Inc.
TCON
ETF Exposure (24)
iShares Micro-Cap ETF
IWC
0.04907%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00814%
iShares Russell 2000 ETF
IWM
0.00658%
iShares Russell 2000 Value ETF
IWN
0.00604%
ProShares Ultra Russell2000
UWM
0.0026970794042103174%
ProShares UltraPro Russell2000
URTY
0.0013287639906379588%
ProShares Hedge Replication ETF
HDG
0.0011241291320272613%
Dimensional U.S. Small Cap ETF
DFAS
3.1141e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
7.739e-5%
Dimensional U.S. Equity ETF
DFUS
6.705e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (17)
Cullinan Oncology, Inc.
CGEM
ORIC Pharmaceuticals, Inc.
ORIC
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Rezolute, Inc.
RZLT
Prelude Therapeutics Incorporated
PRLD
Coherus BioSciences, Inc.
CHRS
Seer, Inc.
SEER
BioAtla, Inc.
BCAB
Spero Therapeutics, Inc.
SPRO
Anebulo Pharmaceuticals, Inc.
ANEB
Protara Therapeutics, Inc.
TARA
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
Bolt Biotherapeutics, Inc.
BOLT
Lyra Therapeutics, Inc.
LYRA
TRACON Pharmaceuticals, Inc.
TCON
ETF Exposure (24)
iShares Micro-Cap ETF
IWC
0.04907%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00814%
iShares Russell 2000 ETF
IWM
0.00658%
iShares Russell 2000 Value ETF
IWN
0.00604%
ProShares Ultra Russell2000
UWM
0.0026970794042103174%
ProShares UltraPro Russell2000
URTY
0.0013287639906379588%
ProShares Hedge Replication ETF
HDG
0.0011241291320272613%
Dimensional U.S. Small Cap ETF
DFAS
3.1141e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
7.739e-5%
Dimensional U.S. Equity ETF
DFUS
6.705e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%